Scott C. Baraban, PhD is Professor of Neurological Surgery and William K. Bowes Jr. Endowed Chair in Neuroscience Research at UCSF where he directs an epilepsy research laboratory in the Department of Neurological Surgery. His pioneering research focuses on translational questions and includes work on models of pediatric epilepsy in zebrafish and interneuron-based cell therapies for epilepsy. The first zebrafish models for epilepsy were developed in his laboratory over 10 years ago, and his group published the first high-throughput drug screens using a zebrafish model for Dravet syndrome. He has authored more than 100 publications, including papers in the Journal of Neuroscience, Proceedings of the National Academy of Sciences USA, Neuron, Nature Communications, Science and Nature Neuroscience. He has received several research honors, including the Basil O’ Connor Scholar Research award, a Klingenstein Foundation Fellowship in Neuroscience and an NIH EUREKA award. He was recently awarded a Javits Neuroscience Investigator Award from the NIH and the Basic Science Research award from the American Epilepsy Society.
Dr. Baraban received his Bachelor’s degree from Johns Hopkins University and Ph.D. from the University of Virginia. He completed postdoctoral training at the University of Washington. He currently serves on the Scientific Advisory Board of the Dravet Syndrome Foundation and Gruppo Famiglie Dravet Associazione of Italy. He is a Co-Founder of EpyGenix Therapeutics.